Stocktoria
Sun Pharmaceutical Industries Limited SUNPHARMA.NS
IN · National Stock Exchange of India · XNSE · stock · Healthcare · website
Sun Pharmaceutical Industries Limited statistics & valuation
Market cap$4.52T
P / E39.4×
P / S7.8×
P / B5.4×
P / FCF51.3×
Dividend yield0.87%
Net margin19.7%
Return on equity13.7%
FCF margin15.1%
Multiples are price-derived and refreshed daily; everything else is from filings.
P / E vs its own history
Sun Pharmaceutical Industries Limited trades at about 39× earnings — near its 10-year norm (10-year range 28×–40.2×, median 37.8×).
28×
40.2×
Shaded band = 10-year range (28×–40.2×); dot = today's 39×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Gross margin | 80.2% | 79.3% | 74.7% | 72.4% |
| Operating margin | 23.3% | 24.0% | 21.9% | 21.4% |
| Net margin | 19.7% | 21.0% | 20.1% | 19.6% |
| FCF margin | 15.1% | 23.0% | 20.8% | 6.6% |
| Return on assets | 10.6% | 11.9% | 11.2% | 10.5% |
| Return on equity | 13.7% | 15.1% | 15.0% | 15.1% |
| Debt / equity | 0.00× | 0.00× | 0.00× | 0.00× |
| Current ratio | 2.82 | 2.89 | 2.56 | 2.00 |
Source: company filings via Yahoo Finance · IN · as of 2026-03-31. Figures in INR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.